PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Federal University of ParanĂ¡ (UFPR); CEPETI, Center for Study and Research in Intensive Care Medicine, Rua Monte Castelo, 366, Curitiba, CEP, 82590-300, Brazil. reaneto@uol.com.br.\', \'CEPETI, Center for Study and Research in Intensive Care Medicine, Rua Monte Castelo, 366, Curitiba, CEP: 82590-300, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-88509-9
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33907251
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all